术前血清肝功能相关指标在结直肠癌的预后价值
Lang Wang1, Jinshan Liu1,2, Can Tan1
1Department of Gastrointestinal Surgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China, 400016.
Medicine
|December 23, 2025
概括
这项研究发现,手术前肝功能标志物性酸酶 (ALP) 和乳酸脱酶 (LDH) 是结直肠癌 (CRC) 存活率的关键指标. 结合这些标记物的新名录模型改善了患者的预后预测.
科学领域:
- 在瘤学瘤学.
- 临床医学 临床医学
- 生物标志物 生物标志物
背景情况:
- 结肠直肠癌 (CRC) 的预后具有挑战性,需要改进预测工具.
- 反映肝功能的血清生物标志物可能提供有价值的预后见解.
- 当前的预后模型往往缺乏全面整合肝功能指标.
研究的目的:
- 调查手术前肝功能指标对CRC患者整体存活时间 (OS) 的影响.
- 开发和验证一种新型的名录模型,用于准确的,个性化的CRC生存预测.
- 确定CRC的关键预后因素,包括血清肝功能标志物.
主要方法:
- 对3938名手术后CRC患者的回顾性分析,分为发展 (n=2758) 和验证 (n=1180) 队列.
- 单变量和多变量考克斯回归分析以确定独立的预后因素.
- 开发和验证一个包含年龄,瘤阶段,瘤大小,术后并发症,手术前性酸酶 (ALP) 和乳酸脱酶 (LDH) 水平的名录.
主要成果:
- 年龄,瘤阶段,瘤大小,术后并发症,术前ALP和LDH水平被确定为CRC预后的独立风险因素.
- 建立的名录表显示出优异的辨别能力,C指数为0.747 (发展) 和0.749 (验证).
- 时间依赖的ROC曲线和校准曲线证实了该模型的良好预测效用和一致性.
结论:
- 手术前血清性酸酶 (ALP) 和乳酸脱酶 (LDH) 水平是结肠直肠癌的显著独立预后因素.
- 开发的诺米图,整合了临床和肝功能参数,为预测CRC患者的术后生存提供了有价值的工具.
- 这种模型可以帮助临床医生做出更明智的决策,为个性化的患者管理和治疗策略做出更明智的决定.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
165
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
165
Serum Laboratory Studies, Stool Test, Breath Test
722
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
722


